Brigitte T. Wildemann

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 234 publications

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Journal: Neurology

Published: July 02, 2026

Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort.

Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 01, 2026

HLA Associations Differ by Ethnicity and Aquaporin-4 Antibody Status in Patients With Neuromyelitis Optica Spectrum Disorders.

HLA Associations Differ by Ethnicity and Aquaporin-4 Antibody Status in Patients With Neuromyelitis Optica Spectrum Disorders.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 16, 2026

Real-world practices and challenges of radiologically isolated syndrome: results of a cross-sector survey by the DACH MS guidelines group.

Real-world practices and challenges of radiologically isolated syndrome: results of a cross-sector survey by the DACH MS guidelines group.

Journal: Frontiers in neurology

Published: March 04, 2026

An autoantibody signature predictive for multiple sclerosis: evidence at the protein level and association with histopathological lesion types.

An autoantibody signature predictive for multiple sclerosis: evidence at the protein level and association with histopathological lesion types.

Journal: Journal of neurology

Published: January 15, 2026

Impact of tobacco and alcohol consumption on disease progression and MRI in people with multiple sclerosis: results of the prospective cohort study NationMS.

Impact of tobacco and alcohol consumption on disease progression and MRI in people with multiple sclerosis: results of the prospective cohort study NationMS.

Journal: Therapeutic advances in neurological disorders

Published: January 07, 2026

Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders.

Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders.

Journal: Neurological research and practice

Published: December 19, 2025

Copine-5-IgG-related autoimmune encephalitis: a novel paraneoplastic neurological syndrome with a strong melanoma association.

Copine-5-IgG-related autoimmune encephalitis: a novel paraneoplastic neurological syndrome with a strong melanoma association.

Journal: Journal of neuroinflammation

Published: December 14, 2025

Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world data.

Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world data.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 25, 2025

Impaired suppressive effect of FoxP3 regulatory T cells on B cells in multiple sclerosis.

Impaired suppressive effect of FoxP3 regulatory T cells on B cells in multiple sclerosis.

Journal: Journal of neuroinflammation

Published: November 05, 2025

Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis.

Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 15, 2025

Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS).

Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS).

Journal: European journal of neurology

Published: August 12, 2025

Showing 1-12 of 234

Last Updated: 09/26/2026